Pluri
Maital (Shemesh) Rasmussen is an accomplished leader in the biotechnology and healthcare sectors, currently serving as the Fractional Chief Commercial Officer and Advisory Board member at GLX Analytix and as an Advisor at Soley Therapeutics and Cleveland Diagnostics, Inc. With a strong background in marketing and business development, Maital has held key positions including Chief Commercial Officer at Octave and Global Head of Marketing at Roche, where significant contributions were made to the launch of innovative healthcare solutions and strategic marketing initiatives. Advisory roles at DeepLook Medical and Pluri further highlight Maital's commitment to advancing personalized medicine and expanding access to effective treatments. Maital holds multiple degrees, including a Master’s in Marketing Communication and Political Science from Columbia University, along with certifications in NLP coaching.
This person is not in any teams
This person is not in any offices
Pluri
3 followers
Pluri is pushing the boundaries of science and engineering to create cell-based products for commercial use and is pioneering a biotech revolution that promotes global wellbeing and sustainability. The Company’s technology platform, a patented and validated state-of-the-art 3D cell expansion system, advances novel cell-based solutions for a range of initiatives— from medicine and climate change to food scarcity, animal cruelty and beyond. Pluri’s method is uniquely accurate, scalable, cost-effective, and consistent from batch to batch. Pluri currently operates in the field of regenerative medicine and food-tech and aims to establish partnerships that leverage the company’s 3D cell-based technology to additional industries that require effective, mass cell production. To learn more, visit us at www.pluri-biotech.com or follow us on LinkedIn and Twitter.